Nutrition General Dietary Guidelines for Children with JRA – Well balanced diet that includes variety of foods – Meals should be planned using Food Pryamid – Serving Sizes appropriate for age.

Download Report

Transcript Nutrition General Dietary Guidelines for Children with JRA – Well balanced diet that includes variety of foods – Meals should be planned using Food Pryamid – Serving Sizes appropriate for age.

Nutrition
General Dietary
Guidelines for
Children with JRA
– Well balanced diet
that includes variety
of foods
– Meals should be
planned using Food
Pryamid
– Serving Sizes
appropriate for age
Nutritional Risk
Growth retardation and impaired bone demineralization occur
during periods of active disease, & are exacerbated by steroid
administration, anorexia, or decreased physical activity.
Anorexia very common
Dietary inadequacies
Limitations in physical
activity
Mechanical feeding
difficulties
Susceptibility to food fads
and quackery
Common Growth Problems in
JRA
Poor linear growth
Low lean body and muscle mass
Undernutrition and wasting
Excessive weight gain & obesity
Leg length discrepancy
Mechanical Feeding Problems
Arthritis of TMJ
– Pain while chewing
– Limitation of opening of mouth
Mechanical Feeding Problems
Arthritis in wrists,
elbows, fingers:
difficulty using utensils
– Embarrassment
– Try to hide this
– Refusal to eat
Solutions:
– Cut up food
– Use easy to grasp
cups
– OT
Unproven Remedies
70% of JRA patients have tried 1 - 8
unconventional remedies
43% tried dietary changes
No evidence that JRA is caused by
food allergies
No evidence that JRA is cured by
anti-allergy diets
Approach to School
Attendance
Absences: due to
– Morning stiffness
and pain
– Flare of disease
activity
– Hospitalizations
– Medical
appointments
(MD, OT/PT)
Frequent absences
Any prolonged absence or frequent 1 or
2 day absences may indicate possible
secondary gain
– Using illness for increased attention,
increased control or avoidance of difficult
situations at school
– Or developing a school phobia
Our Approach to School
Attendance
Identify the school issues
– School checklist
– Interview child and parent
– Talk with school nurse if needed
Send letter listing special needs
Instruct parents to meet with school
principal, counselor, & school nurse
504/IEP staffing if needed
Special School Concerns:
Homebound schooling
Intermittent Schooling: safety net
Full homebound
– reserved for the unusual situations
– a temporary measure
– evaluated regularly by the physician
– for situations of prolonged evaluation &
diagnosis, or flare which kept child out of school
for extended period of time causing child to be
behind in school work.
– Should be a last resort
Special School Concerns:
Mobility problems
Difficulty getting
to school or
waiting for bus.
– Special
transportation
– Arrange to be last
on bus route or
change bus stop
– Schedule least
important classes
in AM
Mobility problems
Difficulties physically getting
from class to class or climbing
stairs
– Allow extra time to get from class to class
– Elevator pass
– Schedule classes close together or
progressively to minimize walking distances
– Plan for extra assistance during fire or
disaster drills or when going on field trips.
– Wheelchair for special circumstances
Stiffness -Sitting in one
position too long
– Allow to move frequently
– Wiggle
– Ask teacher to give errands (hand out
papers)
Special School Concerns:
Problems with manual dexterity
Messy, slow handwriting
Painful, stiff fingers, hands
– Rubber build-ups on pens /
pencils to facilitate a better grip
– Felt tip pens
– Extra time for completion of
assignments & tests
– Modification of assignments
requiring less writing
– Use of tape recorders, computers
– Aide to fill in bubbles
Special School Concerns:
Problems with manual dexterity
Difficulty opening
locker
Difficulty reaching
upper lockers
– Alternative location for
storage of books
– Key lock (easier to
open than combination)
– Books kept in each
classroom
Difficulty eating or
toileting
– Allow extra time
– Assistant
Special School Concerns:
Fatigue
Tires more easily “it feels like I have the flu
all the time”
Trouble keeping up
– Schedule rest period into middle of day
– Allow extra time for completion of assignments
– Assign a tutor
Special School Concerns:
Pain or limited movement in
arms/shoulders/hands
Extra set of
books
Rolling back
pack
Buddy system
Alternative
signaling plan
Keep books in
each classroom
Special School Concerns:
Physical Education
Letter from MD to
specify PE restrictions
Adaptive PE
“Dressing out” - may
have difficulty changing,
need extra time and
assistance
– Loose fitting clothes
– Velcro closures
Schedule in afternoon
when not as stiff
Special School Concerns:
OT/PT
May need
OT/PT
evaluation –
in AM when
joints are
worse
May need
special desk
or chair
Can evaluate
for adaptive
equipment
Special School Concerns:
Psychosocial development
Many children don’t want
peers to know about
their disease
Many make up excuses
to explain why they can’t
run or walk as fast as
peers
Teasing
– Classroom discussion
– Counseling
Arthritis Foundation
Focus: RA, Osteoarthritis and JA
Supports research, public policy
Juvenile Arthritis Alliance: annual
conference
Education and resources
Blogs/groups (kids, tweens, teens, parents)
Advocacy Summit (April 16-18, 2012 in
Washington, DC
Advocacy in Tallahassee
Arthritis Foundation
Camp Boggy
Creek/Camp
Funrise
Regional Family
Fun Days in
Florida
Jingle Bell
Runs/Creaky
Bones Walk/Runs
Joints in Motion
Systemic Lupus Erythematosus
A systemic multi-system autoimmune
disease characterized by the presence of
autoantibodies and multiorgan system
involvement.
+ ANA in >90% of patients with SLE
+ANA is 1:160 or higher
Etiology: combination of genetic
susceptibility and environmental factors,
including exposure to sunlight, infections,
drugs, and chemicals.
SLE in kids facts
15-20% of lupus cases begin before age 19
Incidence & prevalence rates vary by
ethnicity and are higher in Hispanic, Black,
North American First Nations, and SouthEast and South Asian populations
Exposure to UV-B rays may exacerbate
either skin or systemic disease.
Female to male 2:1, 5:1
Mean age at diagnosis 12-13 years
1982 revised criteria for
classification of SLE
Malar rash
SLE criteria
Discoid rash: Erythematous raised
patches with adherent keratotic scales and
follicular plugging. Atrophic scarring.
SLE criteria
Photosensitivity: unusual reaction to
sunlight
Oral ulcers
Arthritis
SLE criteria
Serositis (Pleuritis, documented by ECG
or rub, or evidence of pericardial effusion
Renal disorder (proteinuria or casts)
Neurological disorder (seizures,
psychosis, known metabolic derangement
– uremia, ketoacidosis, electolyte
imbalance
Hematological disorder (hemolytic anemia,
lymphopenia
SLE criteria
Immunological disorder (+DSDNA or
+anti-SM nuclear antigen, or + antiPhospholipid antibody, or + Lupus anticoagulant
ANA
Management of SLE
Calcium + Vitamin D
Sunscreen
NSAIDS
Plaquenil
Oral prednisone – sometimes IV
Methotrexate – steroid sparing (folic acid)
Azathioprine or Cellcept
Cytoxan
Cyclosporin
Juvenile Dermatomyositis
A multisystem disease resulting in chronic
inflammation of striated muscle and skin.
--
Juvenile Dematomyositis
Criteria for diagnosis
– Symmetrical proximal muscle weakness
– Characteristic rash
Heliotrope rash of eyelids & periorbital edema
Erythematous papules over extensor surfaces of
joints including MCPs and PIPs, elbows, knees,
ankles: Gottron papules)
– Increased CK, AST, ALT, LDH, Aldolase
– EMG
– Muscle biopsy
– MRI of thigh muscles (preferred to EMG and
muscle biopsy)
Gottron’s
papules
Scaly
erythematous
rash,
violaceous
discoloration
Incidence: 3.2 new cases per 1 million
children
Rates of blacks and whites =
Hispanic rates slightly less
Median age of onset: 7 years
25% are < 4 years of age
Female to male ratio 2.1:1
Symptoms: present in 79 children
Rash
100%
Weakness
100/%
Muscle pain
73%
Fever
65%
Trouble Swallowing
44%
Hoarseness
43%
Stomach pain
37%
Arthritis
35%
Calcifications
23%
Blood in Stool
13%
Levels of weakness at
Diagnosis
Mild: Can’t run as fast as friends in play
and sports activities, Tires more easily
Moderate: Difficulty combing hair, Loss of
ability to dress self, Trouble getting in and
out of car, C/O aches in muscles after
walking
Severe: Wants to be carried everywhere,
Trouble swallowing, Trouble walking.
Needs help going from lying down to
sitting.
Abnormally prominent
nailfold capillaries and
hemorrhage present in
a patient with
dermatomyositis.
Changes of nailfold
capillary patterns,
characterized by loss of
(drop-out) nailfold
capillary loops that
surround the
remaining, enlarged
dilated capillaries.
Juvenile Dermatomyositis
Treatment
Corticosteroids
IV and/or PO
Methotrexate
Plaquenil
Azathioprine
IVIG 2 gm/kg/mo
Cyclosporin)
Cyclophosphamide
Mycophenolate
mofetil
Prograf (tacrolimus)
Rituximab
Anti-TNF (Enbrel or
Remicade
Dermatomyositis mortality
30% pre-steroid era (Bitnum et al)
10% post-steroids (Spencer et al)
2011: 2 out of 346 (<1%) UK cohort
Prognosis
Normal to good funtional outcome
Minimal atrophy or contracture
Calcinosis
40%
Wheelchair dependence
Death
65-80%
25-30%
205%
1-2%
Juvenile Localized Scleroderma
All types of Scleroderma are characterized
by an excessive accumulation of collagen.
Dermatologists call this morphea. Peds
rheumatologists call it localized
scleroderma. Limited to skin and
subdermal tissues. Rarely internal organs.
– Circumscribed morphea (oval or round areas
of induration
Linear scleroderma (lines of induration) can affect
trunks and limbs or head: involves dermis, subQ
tissue and sometimes muscle and underlying
bone. Can affect the limbs and/or trunk.
– Generalized: induration starting as individual
plaques – 4 or more, and larger than 3 cm.
And involve at least 2 sites
Pansclerotic morphea – Circumferential
involvement of limbs affecting the skin, subq tissue,
muscle and bone. The lesion may involve other
areas of the body without internal organs involved.
Treatment/Prognosis
Very little evidence on which to base
treatment recommendations:
– Solumedrol + SubQ methotrexate: most show
response within 4 months
– If no response: Cellcept
– In study of the linear scleroderma: 50%
showed skin softening of 50% or more OR
had disease resolution by 3.8 years after dx.